Valneva receives ema's positive chmp opinion for adolescent label extension for chikungunya vaccine ixchiq®

If granted, ixchiq ® will become the first vaccine against the chikungunya virus (chikv) available in the eu for adolescents 12 years of age and older

VALN Ratings Summary

VALN Quant Ranking